Tapan Mahendra Kadia (Tapan Kadia, Tapan M Kadia)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 153

Top Venues

American journal of hematology

Cancer

Leukemia

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line BCR::ABL1 Tyrosine Kinase Inhibitors. American journal of hematology (2023)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D Di Nardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D Di Nardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Y Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D Di Nardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D Di Nardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Warren C Fiskus, Christopher P Mill, Christine Birdwell, John A Davis, Kaberi Das, Steffen Boettcher, Tapan Mahendra Kadia, Courtney D Di Nardo, Koichi Takahashi, Sanam Loghavi, Michael J Soth, Tim Heffernan, Gerard M McGeehan, Xinjia Ruan, Xiaoping Su, Christopher R Vakoc, Naval G Daver, Kapil N Bhalla
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood cancer journal 13 (1) (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Hong Fang, Hannah C Beird, Sa A Wang, Andrew F Ibrahim, Zhenya Tang, Guillin Tang, M James You, Shimin Hu, Jie Xu, Shaoying Li, C Cameron Yin, Siba El Hussein, Nhi Le, P Andrew Futreal, Carlos Bueso-Ramos, Beenu Thakral, Tapan Mahendra Kadia, Rebecca Thornton, Latasha Little, Curtis Gumbs, Xingzhi Song, L Jeffrey Medeiros, Wei Wang
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Phillip A Thompson, Michael J Keating, Alessandra Ferrajoli, Nitin Jain, Christine B Peterson, Naveen Garg, Sa A Wang, Jeffrey L Jorgensen, Tapan Mahendra Kadia, Prithviraj Bose, Naveen Pemmaraju, Nicholas James Short, William G Wierda
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Fady Gh Haddad, Koiji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Mahendra Kadia, Nitin Jain, Yesid Alvarado, Nicholas James Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Rashmi Kanagal-Shamana, Musa Ylimaz, Lucia Masarova, Elias J Jabbour, Hagop M Kantarjian
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D Di Nardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D Di Nardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias Jabbour, Tareq Abuasab, Nicholas Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D Di Nardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Miguel Dario Cantu, Rashmi Kanagal-Shamana, Sa A Wang, Tapan Mahendra Kadia, Carlos E Bueso-Ramos, Sanjay S Patel, Julia T Geyer, Wayne Tam, Yazan F Madanat, Peng Li, Tracy I George, Meredith M Nichols, Heesun Joyce Rogers, Yen-Chun Liu, Nidhi Aggarwal, Jason H Kurzer, Danielle L V Maracaja, Eric D Hsi, Feras Zaiem, Daniel Babu, Kathryn Foucar, Dorottya Laczko, Adam Bagg, Attilio Orazi, Daniel A Arber, Robert P Hasserjian, Olga K Weinberg
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology 7 (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Christopher P Mill, Warren C Fiskus, Kaberi Das, John A Davis, Christine E Birdwell, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Koichi Takahashi, Koiji Sasaki, Gerard M McGeehan, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Hagop Kantarjian, Kapil N Bhalla
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1. Leukemia (2023)
Daniel Nguyen, Hagop M Kantarjian, Nicholas James Short, Wei Qiao, Jing Ning, Branko Cuglievan, Naval G Daver, Courtney D Di Nardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Farhad Ravandi-Kashani, Koiji Sasaki, Ghayas C Issa
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jefferey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia Manero, Robert P Hasserjian
Biologic Features and Clinical Outcomes in Newly Diagnosed Myelodysplastic Syndrome with KMT2A rearrangements. American journal of hematology (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias J Jabbour, Tareq Abuasab, Nicholas James Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles G Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Guillermo Montalban Bravo, Gautam Borthakur, Nicholas James Short, Ghayas C Issa, Tapan Mahendra Kadia, Naval G Daver, Guillin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil N Bhalla, Guillermo Garcia Manero, Betul Oran, Courtney D Di Nardo
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D Di Nardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, David London, Guillermo Garcia Manero, Hagop M Kantarjian, Farhad Ravandi-Kashani, Tapan Mahendra Kadia, Marina Y Konopleva, Courtney D Di Nardo, Sherry Pierce, Abdulrazzak Zarifa, Aya A Albittar, Linda L Zhong, Fechukwu O Akhmedzhanov, Muhammad H Arain, Mansour Alfayez, Ahmad Alotaibi, Mehmet Altan, Aung Naing, Tito R Mendoza, Myrna C B Godoy, Girish Shroff, Sang T Kim, Saadia A Faiz, Dimitrios P Kontoyiannis, Fareed Khawaja, Kristofer Jennings, Naval G Daver
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer 128 (14) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia Manero, Xuemei Wang, Keyur Patel, Tapan Mahendra Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian DO, Naval G Daver, Courtney D Di Nardo, Yesid Alvarado, Jeffrey Aldrich, Gautam Borthakur
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia. American journal of hematology 97 (5) (2022)
Gautam Borthakur, Farhad Ravandi, Keyur Patel, Xuemei Wang, Tapan Mahendra Kadia, Courtney D Di Nardo, Guillermo Garcia Manero, Naveen Pemmaraju, Elias J Jabbour, Koichi Takahashi, Maro Ohanian DO, Naval G Daver, Yesid Alvarado, Mark Brandt, Sherry Pierce, Hagop M Kantarjian
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients. American journal of hematology 97 (11) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology (2022)
Sangeetha Venugopal, Courtney D Di Nardo, Sanam Loghavi, Wei Qiao, Farhad Ravandi, Marina Y Konopleva, Tapan Mahendra Kadia, Kapil N Bhalla, Elias J Jabbour, Ghayas C Issa, Walid Macaron, Naval G Daver, Gautam Borthakur, Guillermo Montalban Bravo, Musa Ylimaz, Keyur P Patel, Rashmi Kanagal-Shamana, Kelly Sharon Chien, Abhishek Maiti, Hagop M Kantarjian, Nicholas James Short
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. American journal of hematology 97 (12) (2022)
Daniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamana, Gautam Borthakur, Guillermo Montalban Bravo, Naval G Daver, Courtney D Di Nardo, Nicholas James Short, Musa Ylimaz, Naveen Pemmaraju, Koichi Takahashi, Elias J Jabbour, Sherry Pierce, Marina Y Konopleva, Kapil N Bhalla, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. American journal of hematology 97 (12) (2022)
Hui Yang, Guillermo Garcia Manero, Koiji Sasaki, Guillermo Montalban-Bravo, Zhenya Tang, Yue Wei, Tapan Mahendra Kadia, Kelly Sharon Chien, Diana Rush, Ha Nguyen, Awdesh Kalia, Manjunath Nimmakayalu, Carlos Bueso-Ramos, Hagop M Kantarjian, L Jeffrey Medeiros, Rajyalakshmi Luthra, Rashmi Kanagal-Shamana
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance. Leukemia 36 (9) (2022)
Naval G Daver, Abhishek Maiti, Tapan Mahendra Kadia, Paresh Vyas, Ravindra Majeti, Andrew H Wei, Guillermo Garcia Manero, Charles F Craddock, David A Sallman, Hagop M Kantarjian
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer discovery 12 (11) (2022)
Warren C Fiskus, Steffen Boettcher, Naval G Daver, Christopher P Mill, Koiji Sasaki, Christine E Birdwell, John A Davis, Koichi Takahashi, Tapan Mahendra Kadia, Courtney D DiNardo, Qi Jin, Yuan Qi, Xiaoping Su, Gerard M McGeehan, Joseph D Khoury, Benjamin L Ebert, Kapil N Bhalla
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood cancer journal 12 (1) (2022)
Nicholas James Short, Walid Macaron, Tapan Mahendra Kadia, Courtney D Di Nardo, Ghayas C Issa, Naval G Daver, Sa Wang, Jeff Jorgensen, Daniel Nguyen, Aram Bidikian, Keyur P Patel, Sanam Loghavi, Marina Y Konopleva, Musa Ylimaz, Elias J Jabbour, Abhishek Maiti, Hussein A Abbas, Elizabeth Shpall, Uday Popat, Gheath Al-Atrash, Sherry Pierce, Hagop M Kantarjian, Farhad Ravandi
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. American journal of hematology 97 (11) (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Elias J Jabbour, Nicholas James Short, Nitin Jain, Nadya J Jammal, Jeffrey Jorgensen, Sa Wang, Xuemei Wang, Maro Ohanian DO, Yesid Alvarado, Tapan Mahendra Kadia, Koiji Sasaki, Rebecca Garris, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10 -4 and higher. American journal of hematology 97 (9) (2022)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Joseph D Khoury, Sergej Konoplev, Sanam Loghavi, Keyur Patel, Guillermo Montalban Bravo, Lucia Masarova, Marina Y Konopleva, Hagop Kantarjian
Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 97 (7) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Shilpa Paul, Hagop Kantarjian, Koiji Sasaki, Kayleigh Marx, Nitin Jain, J Michael Savoy, Adam J DiPippo, Nadya Jammal, Guillermo Montalban Bravo, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Farhad Ravandi, Elias J Jabbour
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. American journal of hematology (2022)
Sangeetha Venugopal, Koichi Takahashi, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi, Nicholas James Short, Maro Ohanian, Lucia Masarova, Ghayas C Issa, Xuemei Wang, Bueso-Ramos Carlos, Musa Ylimaz, Tapan Mahendra Kadia, Michael Andreeff, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian, Courtney D Di Nardo
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood cancer journal 12 (1) (2022)
Nicholas James Short, Walid Macaron, Marina Y Konopleva, Farhad Ravandi, Nitin Jain, Ghayas C Issa, Tapan Mahendra Kadia, Koiji Sasaki, Partow Kebriaei, Musa Ylimaz, Philip A Thompson, Koichi Takahashi, Hussein A Abbas, William G Wierda, Rebecca Garris, Hagop M Kantarjian, Elias J Jabbour
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. American journal of hematology 97 (6) (2022)
Curtis A Lachowiez, Patrick K Reville, Hagop M Kantarjian, Elias J Jabbour, Gautam Borthakur, Naval G Daver, Ghayas C Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guillin Tang, Keyur P Patel, Jeffrey Medeiros, Hussein A Abbas, Fady Gh Haddad, Daniel Hammond, Nicholas James Short, Abhishek Maiti, Musa Ylimaz, Koiji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Y Konopleva, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Sanam Loghavi, Courtney D Di Nardo
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 97 (11) (2022)
Jayastu Senapati, Tapan Mahendra Kadia
Which FLT3 Inhibitor for Treatment of AML? Current treatment options in oncology 23 (3) (2022)
Alexandre Bazinet, Faezeh Darbaniyan, Tapan Mahendra Kadia, Sangeetha Venugopal, Rashmi Kanagal-Shamana, Courtney D Di Nardo, Gautam Borthakur, Elias J Jabbour, Naval G Daver, Naveen Pemmaraju, Marina Y Konopleva, Farhad Ravandi, Koiji Sasaki, Kelly S Chien, Danielle Hammond, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer (2022)
Warren C Fiskus, Naval G Daver, Steffen Boettcher, Christopher P Mill, Koiji Sasaki, Christine E Birdwell, John A Davis, Kaberi Das, Koichi Takahashi, Tapan Mahendra Kadia, Courtney D Di Nardo, Francis Burrows, Sanam Loghavi, Joseph D Khoury, Benjamin L Ebert, Kapil N Bhalla
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia 36 (11) (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D Di Nardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Musa Ylimaz, Hagop M Kantarjian, Nicholas James Short, Patrick K Reville, Marina Y Konopleva, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias J Jabbour, Nitin Jain, Ghayas C Issa, Koichi Takahashi, Koiji Sasaki, Maro Ohanian, Sherry Pierce, Guillin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Sa A Wang, Guillermo Garcia Manero, Michael Andreeff, Farhad Ravandi, Naval G Daver
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood cancer journal 12 (5) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Sai Prasad Desikan, Naval G Daver, Courtney DiNardo, Tapan Mahendra Kadia, Marina Y Konopleva, Farhad Ravandi
Resistance to targeted therapies: delving into FLT3 and IDH. Blood cancer journal 12 (6) (2022)
Courtney D Di Nardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Mahendra Kadia, Naval G Daver, Lianchun Xiao, Maria Adeoti, Nicholas James Short, Koji Sasaki, Sa A Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Ylimaz, Nitin Jain, Michael Andreeff, Guillermo Garcia Manero, Steven Kornblau, Farhad Ravandi, Elias J Jabbour, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. American journal of hematology 97 (8) (2022)
Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Vinod Shah, Mirinal S Patnaik, Michelle A Elliott, William J Hogan, Mark R Litzow, Christopher C Hook, Abhishek A Mangaonkar, David Viswanatha, Dong Chen, Animesh D Pardanani, Rhett P Ketterling, Courtney D Di Nardo, Tapan Mahendra Kadia, Farhad Ravandi, Koji Sasaki, Kebede H Begna
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. American journal of hematology 97 (9) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Prajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani, Elias J Jabbour, Nitin Jain, Mary Ayres, Yuling Chen, Michael J Keating, Hagop M Kantarjian, Varsha Gandhi, Tapan Mahendra Kadia
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Cancer (2022)
Warren C Fiskus, Taghi Manshouri, Christine Birdwell, Christopher P Mill, Lucia Masarova, Prithviraj Bose, Tapan Mahendra Kadia, Naval G Daver, Courtney D Di Nardo, Gautam Borthakur, Joseph D Khoury, Srdan Verstovsek, Kapil N Bhalla
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Blood cancer journal 12 (1) (2022)
Patrick K Reville, Koiji Sasaki, Hagop M Kantarjian, Naval G Daver, Musa Ylimaz, Courtney D Di Nardo, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S Mehta, Sherry Pierce, Sergej N Konoplev, Joseph D Khoury, Guillermo Garcia Manero, Marina Y Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Mahendra Kadia
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 97 (3) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D Di Nardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Ghayas C Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas James Short, Fadi Haddad, Zhenya Tang, Keyur Pravinchandra Patel, Branko Cuglievan, Naval G Daver, Courtney D Di Nardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Hagop M Kantarjian, Farhad Ravandi
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood cancer journal 11 (9) (2021)
Kapil Saxena, Shelley M Herbrich, Naveen Pemmaraju, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Sherry A Pierce, Elias J Jabbour, Sa A Wang, Carlos Bueso-Ramos, Sanam Loghavi, Guillin Tang, Cora M Cheung, Lynette Alexander, Steven Kornblau, Michael Andreeff, Guillermo Garcia Manero, Farhad Ravandi, Marina Y Konopleva, Naval G Daver
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer 127 (20) (2021)
Warren C Fiskus, Christopher P Mill, Behnam Nabet, Dimuthu Perera, Christine Birdwell, Taghi Manshouri, Bernardo Lara, Tapan Mahendra Kadia, Courtney D Di Nardo, Koichi Takahashi, Naval G Daver, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Steven M Kornblau, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Sunil Sharma, Matthew Stubbs, Xiaoping Su, Michael R Green, Cristian Coarfa, Srdan Verstovsek, Joseph D Khoury, Christopher R Vakoc, Kapil N Bhalla
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells. Blood cancer journal 11 (5) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A Class, Elias Jabbour, David A Sallman, Anthony Michael Hunter, Christopher Benton, Kelly S Chien, Rajyalakshmi Luthra, Carlos E Bueso-Ramos, Tapan Mahendra Kadia, Michael Andreeff, Rami S Komrokji, Najla H Al Ali, Nicholas James Short, Naval G Daver, Mark J Routbort, Joseph D Khoury, Keyur Pravinchandra Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly A Soltysiak, Olivier Lichtarge, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis. Blood cancer journal 11 (3) (2021)
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D Di Nardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R Rausch, Gautam Borthakur, Marina Y Konopleva, Jorge E Cortes, Tapan Mahendra Kadia
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study. Blood cancer journal 11 (3) (2021)
Abhishek Maiti, Courtney D Di Nardo, Wei Qiao, Tapan Mahendra Kadia, Elias J Jabbour, Caitlin R Rausch, Naval G Daver, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Musa Yilmaz, Yesid Alvarado, Kathryn S Montalbano, Allison Wade, Rita E Maduike, Julio A Guerrero, Kenneth Vaughan, Carol A Bivins, Sherry Pierce, Jing Ning, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis. Cancer 127 (22) (2021)
Courtney D Di Nardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan Mahendra Kadia, Naval G Daver, Maria Adeoti, Nicholas James Short, Koiji Sasaki, Sa Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Elias J Jabbour, Guillermo Garcia Manero, Steven M Kornblau, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Gautam Borthakur, Elias Jabbour, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi
Acute myeloid leukemia: current progress and future directions. Blood cancer journal 11 (2) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Koiji Sasaki, Faezeh Darbaniyan, Elias J Jabbour, Carlos Bueso-Ramos, Yue Wei, Kelly Chien, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Kelly A Soltysiak, Mark Routbort, Keyur Patel, Sherry Pierce, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 127 (19) (2021)
Nitin Jain, Abhishek Maiti, Farhad Ravandi, Marina Y Konopleva, Naval G Daver, Tapan Mahendra Kadia, Naveen Pemmaraju, Nicholas James Short, Partow Kebriaei, Jing Ning, Jorge E Cortes, Elias J Jabbour, Hagop Kantarjian
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American journal of hematology 96 (8) (2021)
Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Marina Y Konopleva, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Rashmi Kanagal-Shamana, Xuemei Wang, Xuelin Huang, Sherry Pierce, Caitlin R Rausch, Jan Burger, Alessandra Ferrajoli, Nitin Jain, Uday Popat, Zeev Estrov, Srdan Verstovsek, Elias J Jabbour, Guillermo Garcia Manero, Hagop Kantarjian
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. American journal of hematology 96 (8) (2021)
Christine Birdwell, Warren C Fiskus, Tapan Mahendra Kadia, Courtney D DiNardo, Christopher P Mill, Kapil N Bhalla
EVI1 dysregulation: impact on biology and therapy of myeloid malignancies. Blood cancer journal 11 (3) (2021)
Hagop M Kantarjian, Kebede H Begna, Jessica K Altman, Stuart L Goldberg, Mikkael A Sekeres, Stephen A Strickland, Martha L Arellano, David F Claxton, Maria R Baer, Marc Gautier, Ellin Berman, Karen Seiter, Scott R Solomon, Gary J Schiller, Selina M Luger, Aleksandra Butrym, Gianluca Gaidano, Xavier G Thomas, Pau Montesinos, David A Rizzieri, Donald P Quick, Parameswaran Venugopal, Rakesh Gaur, Lori J Maness, Tapan Mahendra Kadia, Farhad Ravandi, Marc E Buyse, Judy H Chiao
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer 127 (23) (2021)
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, Rasoul Pourebrahim, Tapan Mahendra Kadia, Caitlin R Rausch, Ken Furudate, Naval G Daver, Yesid Alvarado, Maro Ohanian, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Yilmaz, Guilin Tang, Farhad Ravandi, Hagop M Kantarjian, Courtney D Di Nardo, Marina Y Konopleva
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax. Cancer 127 (20) (2021)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Faezeh Darbaniyan, Maria Tariq Siddiqui, Koiji Sasaki, Yue Wei, Hui Yang, Kelly Sharon Chien, Kiran Naqvi, Elias J Jabbour, Tapan Mahendra Kadia, Naval G Daver, Courtney D Di Nardo, Farhad Ravandi, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Kim-Anh Do, Hagop M Kantarjian, Guillermo Garcia Manero
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS). American journal of hematology 96 (7) (2021)
Caitlin R Rausch, Courtney D Di Nardo, Abhishek Maiti, Nadya J Jammal, Tapan Mahendra Kadia, Kayleigh R Marx, Gautam Borthakur, J Michael Savoy, Naveen Pemmaraju, Adam J DiPippo, Naval G Daver, Serena M Chew, Koiji Sasaki, Ghayas C Issa, Nicholas James Short, Koichi Takahashi, Maro N Ohanian, Jing Ning, Lianchun Xiao, Yesid Alvarado, Dimitrios P Kontoyiannis, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Cancer 127 (14) (2021)
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, Courtney D Dinardo, Farhad Ravandi, Nicholas James Short, Michael Andreeff, Gautam Borthakur, Naval G Daver, Naveen Pemmaraju, Koiji Sasaki, Guillermo Montalban Bravo, Kayleigh R Marx, Sherry Pierce, Uday R Popat, Elizabeth J Shpall, Rashmi Kanagal-Shamana, Guillermo Garcia Manero, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy. Cancer 127 (19) (2021)
Francesco Paolo Tambaro, Harjeet Singh, Emily Jones, Michael Rytting, Kris M Mahadeo, Phillip A Thompson, Naval Daver, Courtney D Di Nardo, Tapan Mahendra Kadia, Guillermo Garcia Manero, Tim Chan, Rutul R Shah, William G Wierda
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia. Leukemia 35 (11) (2021)
Elias J Jabbour, Koiji Sasaki, Nicholas James Short, Farhad Ravandi, Xuelin Huang, Joseph D Khoury, Rashmi Kanagal-Shamana, Jeffrey Jorgensen, Issa F Khouri, Partow Kebriaei, Nitin Jain, Yesid Alvarado, Tapan Mahendra Kadia, Shilpa Paul, Guillermo Garcia Manero, Bouthaina Shbib Dabaja, Jan A Burger, Courtney D Di Nardo, Naval G Daver, Guillermo Montalban Bravo, Musa Yilmaz, Maro Ohanian, Alessandra Ferrajoli, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Susan O'Brien, Hagop M Kantarjian
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer 127 (12) (2021)
Kiyomi Morita, Hagop M Kantarjian, Koiji Sasaki, Ghayas C Issa, Nitin Jain, Marina Konopleva, Nicholas James Short, Koichi Takahashi, Courtney D Di Nardo, Tapan Mahendra Kadia, Guillermo Garcia Manero, Naval G Daver, Guillermo Montalban Bravo, Jorge E Cortes, Farhad Ravandi, Elias J Jabbour
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib. Cancer 127 (15) (2021)
Guillermo Montalban-Bravo, Danielle Hammond, Courtney D Di Nardo, Marina Y Konopleva, Gautam Borthakur, Nicholas James Short, Jorge Ramos-Perez, Veronica Guerra, Rashmi Kanagal-Shamana, Kiran Naqvi, Koiji Sasaki, Elias Jabbour, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval Daver, Zeev Estrov, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Activity of venetoclax-based therapy in chronic myelomonocytic leukemia. Leukemia 35 (5) (2021)
Koiji Sasaki, Hagop M Kantarjian, Nicholas James Short, Bachar Samra, Joseph D Khoury, Rashmi Kanagal-Shamana, Marina Konopleva, Nitin Jain, Courtney D Di Nardo, Rita Khouri, Guillermo Garcia Manero, Tapan Mahendra Kadia, William G Wierda, Issa F Khouri, Partow Kebriaei, Rohtesh S Mehta, Richard E Champlin, Rebecca Garris, Cora Marie Cheung, Naval G Daver, Philip A Thompson, Musa Yilmaz, Farhad Ravandi, Elias J Jabbour
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors. Cancer 127 (15) (2021)
Musa Ylimaz, Naval G Daver, Gautam Borthakur, Tapan Mahendra Kadia, Courtney D Di Nardo, Rashmi Kanagal-Shamana, Sanam Loghavi, Betul Oran, Uday R Popat, Sherry Pierce, Elias J Jabbour, Nicholas James Short, Ghayas Issa, Maro Ohanian DO, Marina Y Konopleva, Keyur Patel, Hagop Kantarjian, Farhad Ravandi
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. American journal of hematology 96 (8) (2021)
Sangeetha Venugopal, Abhishek Maiti, Courtney D Di Nardo, Sanam Loghavi, Naval G Daver, Tapan Mahendra Kadia, Caitlin R Rausch, Yesid Alvarado, Maro Ohanian DO, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Ylimaz, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia. American journal of hematology 96 (5) (2021)
Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D Di Nardo, Mary Alma Welch, Farhad Ravandi
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach. Cancer 127 (8) (2021)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Koiji Sasaki, Lucia Masarova, Kiran Naqvi, Elias J Jabbour, Courtney D Di Nardo, Koichi Takahashi, Marina Konopleva, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Zeev Estrov, Joseph D Khoury, Sanam Loghavi, Kelly A Soltysiak, Sherry Pierce, Carlos Bueso-Ramos, Keyur P Patel, Srdan Verstovsek, Hagop M Kantarjian, Prithviraj Bose, Guillermo Garcia Manero
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. Cancer 127 (17) (2021)
Imane Abou Dalle, Hagop M Kantarjian, Farhad Ravandi, Naval G Daver, Xuemei Wang, Elias J Jabbour, Zeev Estrov, Courtney D Di Nardo, Naveen Pemmaraju, Alessandra Ferrajoli, Nitin Jain, Sa A Wang, Nadya J Jammal, Gautam Borthakur, Kiran Naqvi, Sarah Pelletier, Sherry Pierce, Michael Andreeff, Guillermo Garcia Manero, Jorge E Cortes, Tapan Mahendra Kadia
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission. Cancer 127 (11) (2021)
Yasmin Alwash, Joseph D Khoury, Mehrnoosh Tashakori, Rashmi Kanagal-Shamana, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Marina Y Konopleva, Courtney D Di Nardo, Ghayas C Issa, Sanam Loghavi, Koichi Takahashi, Elias J Jabbour, Veronica Guerra, Steven Kornblau, Hagop Kantarjian, Nicholas James Short
Development of TP53 mutations over the course of therapy for acute myeloid leukemia. American journal of hematology 96 (11) (2021)
Abhishek Maiti, Courtney D Di Nardo, Naval G Daver, Caitlin R Rausch, Farhad Ravandi, Tapan Mahendra Kadia, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C Issa, Nicholas James Short, Musa Yilmaz, Guillermo Montalban-Bravo, Alessandra Ferrajoli, Elias J Jabbour, Nitin Jain, Maro Ohanian, Koichi Takahashi, Phillip A Thompson, Sanam Loghavi, Kathryn S Montalbano, Sherry Pierce, William G Wierda, Hagop M Kantarjian, Marina Y Konopleva
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood cancer journal 11 (2) (2021)
Koiji Sasaki, Tapan Mahendra Kadia, Kebede H Begna, Courtney D Di Nardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Guillermo Montalban Bravo, Lucia Masarova, Sherry Pierce, Marina Y Konopleva, Farhad Ravandi, Ayalew Tefferi, Hagop Kantarjian
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. American journal of hematology (2021)
Nitin Jain, Phillip A Thompson, Jan A Burger, Alessandra Ferrajoli, Koichi Takahashi, Zeev E Estrov, Gautam Borthakur, Prithviraj Bose, Tapan Mahendra Kadia, Naveen Pemmaraju, Koiji Sasaki, Marina Y Konopleva, Elias J Jabbour, Naveen Garg, Xuemei Wang, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Wei Wang, Jeffrey Jorgensen, Sa Wang, Wanda Lopez, Ana Ayala, William Plunkett, Varsha Gandhi, Hagop M Kantarjian, Susan O'Brien, Michael Keating, William G Wierda
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35 (12) (2021)
Nicholas J Short, Marina Y Konopleva, Tapan Mahendra Kadia, Partow Kebriaei, Naval G Daver, Xuelin Huang, Lucia Masarova, Robin Cook, Nitin Jain, Elias J Jabbour, Hagop M Kantarjian, Farhad Ravandi
An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 96 (7) (2021)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Nicholas James Short, Gautam Borthakur, Elias J Jabbour, Hagop M Kantarjian
De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer 127 (12) (2021)
Naseema Gangat, Marina Y Konopleva, Mirinal S Patnaik, Elias J Jabbour, Courtney D Di Nardo, Aref Al-Kali, James M Foran, Ginna L Granroth, Horatiu Olteanu, Tapan Mahendra Kadia, Ayalew Tefferi, Naveen Pemmaraju
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm. American journal of hematology (2021)

Tapan Mahendra Kadia.css-eqlu8i{font-size:small;padding-left:4px;} (Tapan Kadia, Tapan M Kadia)

Publication Activity (10 Years)

Top Topics

Top Venues

Tapan Mahendra Kadia (Tapan Kadia, Tapan M Kadia)